Pharmafile Logo
Pharmafocus logo
Advanced Search

South African study suggests Omicron has a lower risk of hospitalisation than Delta

December 22, 2021
Research and Development

A new South African study suggests that there are reduced risks of hospitalisation and severe disease in people infected with …

News

FDA places clinical hold on use of injectable lenacapavir for HIV treatment

December 22, 2021
Research and Development

The FDA has placed a clinical hold on the use of injectable lenacapavir in borosilicate vials, in all ongoing clinical …

News
fgfwekgwyam8rvv

EMA recommends Nuvaxovid for authorisation, as WHO grants second Emergency Use Listing

December 22, 2021
Research and Development

Nuvaxovid™, the COVID-19 vaccine manufactured by the biotechnology company Novavax, has been listed for emergency use by WHO. The news …

News

FDA approves first injectable treatment for HIV pre-exposure prevention

December 21, 2021
Manufacturing and Production

The FDA have approved Apretude (cabotegravir extended-release injectable suspension), for use in at-risk adults and adolescents weighing at least 35 …

News
moderna_norwood_plant

Moderna CEO says Omicron booster could begin development within weeks

December 21, 2021
Medical Communications

Stephane Bancel, CEO of Moderna, said that the company could begin work on a booster shot against the Omicron variant …

News

FDA approves bipolar depression treatment for broad range of adults

December 21, 2021
Manufacturing and Production

Intra-Cellular Therapies, a biopharmaceutical company focused on the development and commercialisation of therapeutics for central nervous system (CNS) disorders, have …

News

Vifor Pharma announces positive results from Phase IIIb trial of heart failure treatment

December 21, 2021
Medical Communications

Vifor Pharma has announced positive findings for the completed Phase IIIb DIAMOND trial of Veltassa, in heart failure patients with …

News

Positive CHMP opinion for sickle cell disease anaemia tablet

December 20, 2021
Sales and Marketing

Global Blood Therapeutics (GBT) have announced the CHMP adopted a positive opinion recommending marketing authorisation for Oxbryta®  (vocelotor) tablets. Oxbryta …

News

FDA approval of Tezspire for severe asthma

December 20, 2021
Sales and Marketing

Tezpire (tezepelumab-ekko), manufactured by AstraZeneca and Amgen, has been approved in the US for the add-on maintenance treatment of adult …

News

Study reveals potential link between COVID-19 and Parkinson’s Disease

December 20, 2021
Sales and Marketing

Scientists in The Netherlands have detailed a possible correlation between COVID-19 and the onset of Parkinson’s disease. The findings may …

News

New COVID-19 drug Sotrovimab becomes available on NHS

December 20, 2021
Sales and Marketing

Sotrovimab, commercially known as Xevudy, is now available on the NHS to reduce the risk of vulnerable patients needing hospitalisation …

News

CDC recommends mRNA vaccines over J&J

December 17, 2021
Medical Communications

The CDC has recommended Pfizer-BioNTech and Moderna COVID-19 vaccines over Johnson & Johnson jabs. The recommendation from CDC Director Dr …

News

COVID-19 booster vaccine triggers immune response in days, not weeks, scientists say

December 17, 2021
Medical Communications

COVID-19 booster jabs trigger an immune response in a matter of days, rather than weeks, scientists have shared. Data suggests …

News

NICE recommends offering PrEP to those at high risk of HIV

December 17, 2021
Medical Communications

People at the highest risk of catching HIV should be offered Pre Exposure Prophylaxis (PrEP), NICE has recommended for the …

News

Omicron grows 70 times faster than Delta in bronchial tissue

December 16, 2021
Business Services

The COVID-19 variant, Omicron, has been found to replicate around 70 times faster than the original and Delta variants of …

News

Potential drugs for AMD treatment identified using stem-cell based research

December 16, 2021
Business Services

Researchers at the National Institutes of Health (NIH) have identified two drug candidates to slow dry age-related macular degeneration (AMD), …

News

FDA pauses several trials of Merck’s investigational HIV drug

December 16, 2021
Business Services

The FDA has placed holds on several clinical trials for the oral and implant formulations of investigation drug islatravir (MK-8591), …

News

European Commission backs Johnson & Johnson COVID-19 booster for adults

December 16, 2021
Business Services

The EC has recommended a booster dose of Johnson & Johnson’s COVID-19 vaccine at least two months after a first …

News

Pfizer shares efficacy of COVID pill: near 90% protection against hospitalisation

December 15, 2021
Research and Development

Pfizer have announced that a final analysis of the antiviral pill Paxlovid (nirmatrelvir tablets and ritonavir tablets) shows 89% reduction …

News

Bionaut Labs and Candel Therapeutics collaborate to deliver immunotherapies

December 15, 2021
Research and Development

Bionaut Labs, and Candel Therapeutics, have announced a strategic collaboration to investigate the use of Bionaut’s remote-controlled microscale robots for …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025